Cite
Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: Implications for peptide vaccines.
MLA
Mitchell, Daniel, et al. “Toll-like Receptor-Mediated Adjuvanticity and Immunomodulation in Dendritic Cells: Implications for Peptide Vaccines.” Human Vaccines, vol. 7, Jan. 2011, pp. 85–93. EBSCOhost, https://doi.org/10.4161/hv.7.0.14567.
APA
Mitchell, D., Yong, M., Raju, J., Willemsen, N., Black, M., Trent, A., Tirrell, M., & Olive, C. (2011). Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: Implications for peptide vaccines. Human Vaccines, 7, 85–93. https://doi.org/10.4161/hv.7.0.14567
Chicago
Mitchell, Daniel, Michelle Yong, Jyothy Raju, Nicole Willemsen, Matthew Black, Amanda Trent, Matthew Tirrell, and Colleen Olive. 2011. “Toll-like Receptor-Mediated Adjuvanticity and Immunomodulation in Dendritic Cells: Implications for Peptide Vaccines.” Human Vaccines 7 (January): 85–93. doi:10.4161/hv.7.0.14567.